6.1 Brevetto
 Distribuzione geografica
Continente #
EU - Europa 4.767
NA - Nord America 4.530
AS - Asia 1.080
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 10.399
Nazione #
US - Stati Uniti d'America 4.519
IT - Italia 1.424
SE - Svezia 1.126
IE - Irlanda 759
CN - Cina 461
DE - Germania 412
TR - Turchia 405
UA - Ucraina 370
GB - Regno Unito 229
VN - Vietnam 150
FI - Finlandia 128
CH - Svizzera 114
RU - Federazione Russa 96
AT - Austria 45
SG - Singapore 43
EU - Europa 21
AL - Albania 17
BE - Belgio 16
CA - Canada 11
FR - Francia 11
NL - Olanda 9
KR - Corea 7
IN - India 4
PK - Pakistan 4
HK - Hong Kong 2
HU - Ungheria 2
IR - Iran 2
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ES - Italia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
ME - Montenegro 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 10.399
Città #
Pisa 959
Jacksonville 864
Dublin 759
Chandler 751
Izmir 404
Wilmington 365
Ann Arbor 328
Ashburn 272
Düsseldorf 181
Millbury 176
Boston 169
Dong Ket 150
San Mateo 116
Boardman 108
Mestre 108
Beijing 98
Bern 92
Woodbridge 85
Seattle 84
Dearborn 79
Bremen 76
Lawrence 71
Ogden 66
Scuola 65
Princeton 55
Milan 44
Saint Petersburg 43
Vienna 41
Guangzhou 39
San Giuliano Terme 39
Chicago 35
New York 34
Nanjing 21
Padova 21
Shanghai 21
Kunming 18
Zurich 18
Hefei 17
Singapore 17
Helsinki 16
Washington 16
Brussels 15
Wuhan 15
Andover 14
Norwalk 14
Jiaxing 13
Bientina 12
Yiwu 12
Cambridge 11
Fairfield 11
Jinan 8
San Diego 8
Wuxi 8
Nanchang 7
Seoul 7
Verona 7
Florence 6
Serra 6
Toronto 6
Berlin 5
Centrale 5
Hangzhou 5
Nuremberg 5
Shaoxing 5
Auburn Hills 4
Chengdu 4
Graz 4
Houston 4
Jinhua 4
Lausanne 4
Rome 4
Tiantai Chengguanzhen 4
Zhengzhou 4
Brescia 3
Cascina 3
Chantilly 3
Fuzhou 3
Gorizia 3
Leawood 3
Lodi 3
Lucca 3
Quzhou 3
Rho 3
Shenzhen 3
Trumbull 3
Budapest 2
Castelfranco Veneto 2
Castiglione dei Pepoli 2
Chizhou 2
Dalian 2
Faisalabad 2
Grevenbroich 2
Hanover 2
Lahore 2
Livorno 2
Los Angeles 2
Montreal 2
Mumbai 2
Nanning 2
Piombino 2
Totale 7.228
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 184
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 162
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 161
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 161
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 158
Composti particolarmente catalizzatori di poliuretani 150
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 137
Method and device for measuring position and mass 136
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 133
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 132
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 132
null 129
Bucket brigade address decoding architecture for classical and quantum random access memories 125
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 124
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 124
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 118
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 114
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 112
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 109
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 108
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 105
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 104
Method for the humanization of antibodies and humanized antibodies thereby obtained 102
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 101
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 100
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 100
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 99
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 98
Method for the humanization of antibodies and humanized antibodies thereby obtained 98
Laser circolari a semiconduttore con reticoli per emissione verticale 97
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 95
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 95
Method for the humanization of antibodies and humanized antibodies thereby obtained. 93
INTRACELLULAR ANTIBODIES 93
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 93
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 92
Intracellular selection 92
Method of identifying a consensus sequence for intracellular antibodies 92
Method for the potentiation of opioid analgesics effects on pain 91
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 89
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 89
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 89
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 89
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 88
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 87
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 87
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 87
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 86
Intracellular selection 86
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 86
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 86
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 85
Method for the humanization of antibodies and humanized antibodies thereby obtained 85
Intracellular selection 85
Selection of intracellular immunoglobulins 85
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 84
Non-human transgenic animals for the study of neurodegenerative syndromes 84
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 84
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 84
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 84
Humanized anti-NGF antibodies 84
Method for the potentiation of opioid analgesics effects on pain 84
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 83
Method for the humanization of antibodies and humanized antibodies thereby obtained. 83
Humanized anti-NGF antibodies 83
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 83
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 83
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 83
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 82
Method for the humanization of antibodies and humanized antibodies thereby obtained. 82
INTRACELLULAR ANTIBODIES 82
Humanized anti-NGF antibodies 81
Novel analgesic treatment with prolonged effect 81
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 80
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 80
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 80
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 80
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 80
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 79
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 79
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 79
Method for the humanization of antibodies and humanized antibodies thereby obtained. 79
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 79
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 78
Method for the humanization of antibodies and humanized antibodies thereby obtained. 78
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 78
Selection of intracellular immunoglobulins 78
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 78
Selection of intracellular immunoglobulins 78
Novel analgesic treatment with prolonged effect 77
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 77
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 76
Selection of intracellular immunoglobulins 76
Novel analgesic treatment with prolonged effect 76
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 76
Method for the humanization of antibodies and humanized antibodies thereby obtained 74
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 74
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 74
Humanized anti-NGF antibodies 73
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 71
Totale 9.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.111 135 105 22 1 132 68 267 42 133 56 127 23
2020/20211.736 129 8 355 10 115 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/202581 81 0 0 0 0 0 0 0 0 0 0 0
Totale 10.531